X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   MYLAN
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
MYLAN
Dec-14
ALKEM LABORATORIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,5894,119-   
Low Rs1,2322,903-   
Sales per share (Unadj.) Rs417.51,410.1-  
Earnings per share (Unadj.) Rs56.3169.9-  
Cash flow per share (Unadj.) Rs64.7273.4-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9700.9-  
Shares outstanding (eoy) m119.57378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.42.5 135.7%   
Avg P/E ratio x25.120.7 121.2%  
P/CF ratio (eoy) x21.812.8 169.8%  
Price / Book Value ratio x4.85.0 96.1%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6531,328,377 12.7%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM21,341.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,570.9-  
INCOME DATA
Net Sales Rs m49,915533,529 9.4%  
Other income Rs m1,645-3,110 -52.9%   
Total revenues Rs m51,561530,419 9.7%   
Gross profit Rs m8,482132,691 6.4%  
Depreciation Rs m1,00639,185 2.6%   
Interest Rs m67123,014 2.9%   
Profit before tax Rs m8,45167,382 12.5%   
Minority Interest Rs m-114-276 41.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6062,834 56.7%   
Profit after tax Rs m6,73164,272 10.5%  
Gross profit margin %17.024.9 68.3%  
Effective tax rate %19.04.2 451.9%   
Net profit margin %13.512.0 111.9%  
BALANCE SHEET DATA
Current assets Rs m27,062469,043 5.8%   
Current liabilities Rs m15,324366,698 4.2%   
Net working cap to sales %23.519.2 122.6%  
Current ratio x1.81.3 138.1%  
Inventory Days Days6778 85.2%  
Debtors Days Days41107 38.5%  
Net fixed assets Rs m12,610123,430 10.2%   
Share capital Rs m23918,867 1.3%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,027265,217 13.2%   
Long term debt Rs m1,212396,208 0.3%   
Total assets Rs m54,3871,068,268 5.1%  
Interest coverage x13.63.9 346.3%   
Debt to equity ratio x01.5 2.3%  
Sales to assets ratio x0.90.5 183.8%   
Return on assets %13.68.2 166.6%  
Return on equity %19.224.2 79.3%  
Return on capital %24.913.6 182.4%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,25970,133 10.3%  
From Investments Rs m1,864-55,309 -3.4%  
From Financial Activity Rs m-9,273-18,480 50.2%  
Net Cashflow Rs m-150-3,656 4.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.11 Rs / USD

Compare ALKEM LABORATORIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: FULFORD INDIA  CADILA HEALTHCARE  WYETH LTD  DIVIS LABORATORIES  JUBILANT LIFE SCIENCES  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 20, 2019 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS